Anastrozole-related acute hepatitis with autoimmune features: A case report

BMC Gastroenterology

Volumn 11, Issue , 2011, Pages

  Inno, Alessandro ^a   Basso, Michele ^a   Vecchio, Fabio M ^a   Marsico, Valentina A ^a   Cerchiaro, Eleonora ^a   D'Argento, Ettore ^a   Bagalà, Cinzia ^a   Barone, Carlo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Anastrozoledrug induced liver injuryautoimmune hepatitishepatotoxicityantinuclear antibodies; case report

Indexed keywords

ANASTROZOLE; ANTINUCLEAR ANTIBODY; BISOPROLOL; ESTROGEN RECEPTOR; KI 67 ANTIGEN; MANIDIPINE; RAMIPRIL; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; AROMATASE INHIBITOR; NITRILE; TRIAZOLE DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ACUTE HEPATITIS; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; ASTHENIA; AUTOIMMUNITY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOGRAPHY; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER INJURY; SEGMENTAL MASTECTOMY; SIDE EFFECT; ACUTE DISEASE; AUTOIMMUNE HEPATITIS; BLOOD; BREAST TUMOR; CARCINOMA; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ANTIBODIES, ANTINUCLEAR; ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; BREAST NEOPLASMS; CARCINOMA; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; NITRILES; TREATMENT OUTCOME; TRIAZOLES;

EID: 79953206307     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-11-32     Document Type: Article

References (15)

1. Iwase H. Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancer. Breast cancer 2008, 15:278-290. 10.1007/s12282-008-0071-y, 18810576.
2. Janni W, Hepp P. Adjuvant aromatase inhibitor therapy: outcomes and safety. Cancer Treat Rev
3. Zapata E, Zubiaurre L, Bujanda L, Piérola A. Anastrozole-induced hepatotoxicity. Eur J Gastroenterol Hepatol 2006, 18:1233-1234. 10.1097/01.meg.0000243868.64078.af, 17033446.
4. de La Cruz L, Romero-Vazquez J, Jiménez-Sáenz M, Padron JR, Herreiras-Gutierrez JM. Severe acute hepatitis in a patient treated with anastrozole. Lancet 2007, 369:23-24. 10.1016/S0140-6736(07)60017-8, 17208628.
5. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RNM, Phillips M, Portmann BG, Poulsen H, Scheuer PJ, Schimd M, Thaler H. Histological grading and staging of chronic hepatitis. J Hepatol 1995, 22:696-699. 10.1016/0168-8278(95)80226-6, 7560864.
6. The Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol 2006, 7:633-643. 10.1016/S1470-2045(06)70767-7, 16887480, The Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group.
7. Danan G, Benichou C. Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993, 46:1323-1330. 10.1016/0895-4356(93)90101-6, 8229110.
8. Grimm SW, Dyroff MC. Inhibition of human drug metabolizing cytochromes P450 by anastrozole, a potent and selective inhibitor of aromatase. Drug Metab Dispos 1997, 25:598-602.
9. Horikiri Y, Suzuki T, Mizobe M. Pharmacokinetics and metabolism of bisoprolol enantiomers in humans. J Pharm Sci 1998, 87:289-294. 10.1021/js970316d, 9523980.
10. Katoh M, Nakajima M, Shimada N, Yamazaki H, Yokoi T. Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions. Eur J Clin Pharmacol 2000, 55:843-852. 10.1007/s002280050706, 10805063.
11. Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, Bittencourt PL, Porta G, Boberg KM, Hofer H, Bianchi FB, Shibata M, Schramm C, Eisenmann de Torres B, Galle PR, McFarlane I, Dienes HP, Lohse AW, . International Autoimmune Hepatitis Group Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008, 48:169-176. 10.1002/hep.22322, 18537184, International Autoimmune Hepatitis Group.
12. Björnsson E, Talwalkar J, Treeprasertsuk S, Kamath PS, Takahashi N, Sanderson S, Neuhauser M, Lindor K. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology 2010, 51:2040-2048.
13. Laroche M, Borg S, Lassoued S, De Lafontan B, Roché H. Joint pain with aromatase inhibitors: abnormal frequency of Sjogren's syndrome. J Rheumatol 2007, 34:2259-2263.
14. Conti-Beltraminelli M, Pagani O, Ballerini G, Richetti A, Graffeo R, Ruggeri M, Forni V, Pianca S, Schönholzer C, Mainetti C, Cavalli F, Goldhirsch A. Henoch-Schönlein purpura (HSP) during treatment with anastrozole. Ann Oncol 2007, 18:205-207. 10.1093/annonc/mdl350, 17043095.
15. Morel B, Marotte H, Miossec P. Will steroidal aromatase inhibitors induce rheumatoid arthritis?. Ann Rheum Dis 2007, 66:557-558. 10.1136/ard.2006.066159, 1856055, 17360783.